Table 4 Distribution of VF genes in relation to fluoroquinolone resistance status among E. coli ST131 isolates from women
Trait | Number (%) of isolates with trait by source and ST131 status | P value by isolate source (vs. ST131)a | ||||
|---|---|---|---|---|---|---|
Fecal (n = 23) | Clinical (n = 131) | |||||
FQ-R-ST131 (n = 7) | FQ-S-ST131 (n = 16) | FQ-R-ST131 (n = 65) | FQ-S-ST131 (n = 59) | Fecal | Clinicalb | |
ESBL | 3 (42) | 1 (6) | 50 (77) | 26 (44) |  < 0.001 | < 0.001 |
O25b | 7 (100) | 16 (100) | 55 (85) | 50 (94) | NS | NS |
O16 | 0 (0) | 0 (0) | 10 (15) | 3 (5) | NS | < 0.001 |
VF genesc | ||||||
afa/draBC | 1 (14) | 3 (19) | 6 (9) | 14 (24) | NS | < 0.001 |
bmaE | 0 (0) | 0 (0) | 1 (2) | 0 (0) | NS | NS |
sfaS | 1 (14) | 3 (19) | 7 (11) | 14 (24) | NS | < 0.001 |
fimH | 7 (100) | 16 (100) | 65 (100) | 59 (100) | NS | NS |
focG | 2 (29) | 7 (44) | 44 (68) | 17 (29) | 0.041 | < 0.001 |
papGI | 0 (0) | 0 (0) | 0 (0) | 1 (2) | NS | NS |
papGII | 1 (14) | 4 (25) | 25 (38) | 10 (17) | 0.031 | < 0.001 |
papGIII | 1 (14) | 3 (19) | 20 (31) | 7 (12) | 0.041 | < 0.001 |
papAH | 2 (29) | 7 (44) | 46 (71) | 19 (32) | 0.032 | < 0.001 |
papC | 2 (29) | 5 (31) | 44 (68) | 21 (36) | NS | < 0.001 |
papEF | 2 (29) | 4 (25) | 44 (68) | 19 (32) | NS | < 0.001 |
gafD | 0 (0) | 0 (0) | 1 (2) | 0 (0) | NS | NS |
cnf1 | 1 (14) | 3 (19) | 44 (68) | 18 (31) | NS | < 0.001 |
hlyA | 1 (14) | 3 (19) | 47 (72) | 187(29) | NS | < 0.001 |
iutA | 7 (100) | 16 (100) | 65 (100) | 59 (100) | NS | NS |
fyuA | 5 (71) | 11 (69) | 65 (100) | 47 (80) | NS | 0.01 |
iroN | 3 (43) | 6 (38) | 57 (88) | 25 (42) | NS | < 0.001 |
kpsMTII | 1 (14) | 5 (31) | 33 (51) | 59 (100) | 0.028 | NS |
KpsMTIII | 0 (0) | 0 (0) | 0 (0) | 0 (0) | NS | NS |
traT | 7 (100) | 16 (100) | 65 (100) | 59 (100) | NS | NS |
ompT | 7 (100) | 16 (100) | 65 (100) | 59 (100) | NS | NS |
usp | 7 (100) | 16 (100) | 65 (100) | 59 (100) | NS | NS |